1. Saudi Arabia Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Dr. Sulaiman Al-Habib Medical Services Group Co.

Dr. Sulaiman Al-Habib Medical Services Group Co.

TTADAWUL:4013
209.90
SAR
-5.30
(-2.46%)
74.20BMarket Cap
Dr. Sulaiman Al-Habib Medical Services Group Co.
TADAWUL:4013
(Saudi Exchange)

Recent

price

209.90

P/E

ratio

- -

div

yld

1.68%

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
SAR
14.33
16.75
20.72
23.74
27.17
32
39.16
- -
Revenue per Share
2.49
3.02
3.93
4.72
5.85
6.62
6.86
- -
Basic EPS, GAAP
0.93
4.06
2.66
3.8
-0.72
-2.45
1.2
- -
Free Cash Flow per Basic Share
2.58
1.5
2.7
3.25
4.1
4.69
4.75
3.53
Dividend per Share
12.55
14.03
15.25
16.8
18.53
20.5
22.58
23.6
Book Value per Share
12.55
14.03
15.25
16.8
18.53
20.5
22.58
23.6
Tangible Book Value per Share
350
350
350
350
350
350
350
350
Basic Weighted Avg Shares
5,016
5,862
7,250
8,311
9,508
11,200
13,707
- -
Sales/Revenue/Turnover
17.44
19.12
20.37
20.6
22.18
21.19
19.26
- -
Operating Margin (%)
256
318
315
309
313
421
672
- -
Depreciation Expense
870
1,055
1,377
1,651
2,046
2,315
2,401
- -
Net Income, GAAP
7.27
8.23
7.6
5.99
3.16
1.78
1.1
- -
Effective Tax Rate (%)
17.35
18.01
18.99
19.86
21.52
20.67
17.52
- -
Profit Margin (%)
1,790
2,100
2,086
1,570
839
1,158
709
668
Working Capital
2,049
2,262
2,698
3,310
5,046
7,995
9,108
9,294
LT Debt
4,591
5,089
5,527
6,106
6,766
7,613
8,429
8,842
Total Equity
- -
13.96
16.65
17.63
19.06
16.95
15.55
- -
Return on Invested Capital (%)
- -
15.3
17.19
18.22
19.08
17.46
15.79
- -
Return on Capital (%)
- -
22.68
26.86
29.43
33.1
33.9
31.86
- -
Return on Common Equity (%)

Capital Structure

SAR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
196
167
378
LT Borrowings
8,735
8,976
8,943
LT Finance Leases
374
359
351
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
350
350
350
Market Capitalization
89,950
90,440
74,200

Working Capital

SAR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
5,427
5,647
6,199
Cash, Cash Equivalents & STI
2,282
2,415
2,322
Accounts Receivable, Net
1,622
1,629
1,937
Inventories
1,028
1,154
1,235
Total Current Liabilities
4,719
4,955
5,532
Payables & Accruals
- -
- -
- -
ST Debt
196
167
378
Deferred Revenue
- -
- -
- -

Growth Rates

SAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
10.63%
10.72%
Free Cash Flow
- -
-3.93%
-148.78%
Net Income, GAAP
- -
18.23%
3.72%
Sales/Revenue/Turnover
- -
18.58%
22.38%
Total Cash Common Dividend
- -
28.44%
1.28%

Quarterly Revenue

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,521
2,574
2,977
3,129
11,200
2025
3,158
3,384
- -
3,701
13,707
2026
3,436
4,006
- -
- -
- -

Quarterly Earnings Per Share

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.57
1.59
1.7
1.75
6.62
2025
1.59
1.69
- -
1.86
6.86
2026
1.44
1.89
- -
- -
- -

Quarterly Dividends Per Share

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.15
1.17
1.17
1.2
4.69
2025
1.23
1.12
- -
1.21
4.75
2026
1.31
1.01
- -
- -
- -
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) operates as a leading provider of integrated private healthcare services in Saudi Arabia and the GCC region. The company establishes, manages, and operates hospitals, general and specialized medical complexes, day surgery centers, primary care medical centers, and pharmaceutical facilities; it also delivers ancillary services including laboratory testing through MD Lab, healthcare IT solutions via its wholly-owned subsidiary Cloud Solutions Company (featuring the award-winning VIDA hospital information system), integrated healthcare technologies from Flow Medical Solutions, and revenue cycle management through Taswyat Management Company. Spanning over 60 medical specialties with centers of excellence in areas such as orthopedics, ophthalmology, and plastic surgery, the group serves more than three million patients annually across its network of over 20 hospitals and medical centers in Saudi Arabia, the United Arab Emirates, and Bahrain, supported by more than 1,900 beds, 1,370 clinics, and a network of pharmacies. Founded in 1993 and headquartered in Riyadh, Saudi Arabia, the company maintains a workforce exceeding 13,000 employees and aligns its expansions with Saudi Vision 2030 to enhance private sector participation in healthcare. In recent developments, the group has aggressively expanded its capacity by approximately 80% from FY23 levels through FY24 and H1 FY25, adding around 580 beds via three new facilities including Al Sahafa Hospital, Gharb Jeddah Women's Health Hospital, and upcoming sites in Al-Kharj and North Jeddah's Alhamra, while reporting net income growth of 6.5% year-over-year to SAR 591 million in Q2 2025. In November 2024, Dr. Sulaiman Al Habib Medical Services Group reinforced its strategic partnership with GE HealthCare, investing in advanced MRI systems, over 1,000 patient monitors and cardiology equipment, ultrasound solutions, and the global debut of the Portrait VSM Vital Signs Monitor (500 units) across its network to bolster diagnostics, patient monitoring, and alignment with Vision 2030 healthcare goals. These initiatives, including ongoing construction of three additional facilities and projected revenue/net income CAGRs of 13.2%/17.0% through FY29, underscore the company's focus on technological innovation, operational ramp-ups, and regional growth.